DNA 클래스 A Ginkgo Bioworks Holdings, Inc. Class A Common Stock
NYSE · Life Sciences Tools & Services · SEC EDGAR에서 보기 ↗ 종가 10월 2, 2026 10-K/10-Q 8월 6, 2026
$12.35
· 52주 범위 %
· 저점 이상
· 고점까지
$5.3752주 저점
$17.5852주 고점
시가총액 (MRQ)
$787M
P/E
-2.3
EPS
$-5.64
매출
$170M
내 배지
52주 범위
$5–$18
애널리스트 평점
SELL
목표 주가
$7
P/E
-2.3
ROE
-55.8%
순이익률
-260.0%
배지 스트립이 비어 있습니다. 이 페이지의 아무 지표나 고정하세요.
DNA 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$12.35
시가총액 (MRQ)
$787M
P/E
-2.3
EPS
$-5.64
매출
$170M
ROE
-55.8%
52주 범위
$5–$18
DNA 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
범위
막대
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
주식 분할
| 배당락일 | 분할 | 유형 |
|---|---|---|
| 2024년 8월 20일 | 1-for-40 | 역방향 |
Ginkgo Bioworks Holdings, Inc. Class A Common Stock 정보 위키백과 회사 개요
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
History
In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.
On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.
Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.
On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.
On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.
On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.
On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.
On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.
On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.
In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.
Fraud allegations
On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.
In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
섹터Healthcare
산업Life Sciences Tools & Services
직원485
국가US
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출$170M2019-12-31 → 2025-12-31
EPS$-5.642019-12-31 → 2025-12-31
잉여현금흐름$-179M2022-12-31 → 2025-12-31
순이익률-260.0%2022-12-31 → 2025-12-31
가치 평가 및 비율
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
| 지표 | 5년 추세 | DNA | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| P/E | -2.35년 평균 ≈-49.3 | ≈-49.3 | · | · | |
| P/S (TTM) | 7.05년 평균 ≈202.7 | ≈202.7 | · | · | |
| P/B (MRQ) | 1.95년 평균 ≈49.7 | ≈49.7 | · | · | |
| 주가 / FCF (TTM) | -4.55년 평균 ≈-206.6 | ≈-206.6 | · | · | |
| 주가 / 현금 흐름 (TTM) | -4.65년 평균 ≈-242.4 | ≈-242.4 | · | · | |
| 주가 / 유형 장부 가치 (MRQ) | 2.15년 평균 ≈115.0 | ≈115.0 | · | · |
동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
| 지표 | 5년 추세 | DNA | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 영업이익률 (TTM) | -259.9%5년 평균 ≈-309.5% | ≈-309.5% | · | · | |
| EBITDA Margin (EBITDA 마진) | -185.3%5년 평균 ≈-309.5% | ≈-309.5% | · | · | |
| 세전 마진 (TTM) | -264.1%5년 평균 ≈-306.2% | ≈-306.2% | · | · | |
| 순이익률 (TTM) | -260.0%5년 평균 ≈-305.1% | ≈-305.1% | · | · | |
| ROA | -25.1%5년 평균 ≈-48.7% | ≈-48.7% | · | · | |
| ROE | -55.8%5년 평균 ≈-84.1% | ≈-84.1% | · | · | |
| ROIC | -61.8%5년 평균 ≈-86.3% | ≈-86.3% | · | · |
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
| 지표 | 5년 추세 | DNA | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 유동비율 (MRQ) | 4.65년 평균 ≈6.3 | ≈6.3 | · | · | |
| Quick Ratio (당좌 비율) | 4.75년 평균 ≈6.0 | ≈6.0 | · | · |
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
| 지표 | 5년 추세 | DNA | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Revenue YoY (매출 YoY) | -25.1%5년 평균 ≈55.9% | ≈55.9% | · | · | |
| Revenue CAGR 3Y (매출 CAGR 3년) | -29.1%5년 평균 ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 5Y (매출 CAGR 5년) | 17.3% | · | · | · |
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
| 지표 | 5년 추세 | DNA | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Asset Turnover (자산 회전율) | 0.15년 평균 ≈0.2 | ≈0.2 | · | · | |
| Receivables Turnover (매출 채권 회전율) | 7.45년 평균 ≈7.2 | ≈7.2 | · | · | |
| Revenue / Employee (연간 매출액 ÷ 직원 수(yfinance 보고 인원수). 파생 — 저장된 SEC-XBRL 개념이 아님.) | ≈$350.8K | · | · | · |
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
2.6%
| 기간 | 보고서 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|---|
| 2026년 6월 30일 | $-0.75 | $-0.92 | 18.4% | |
| 2026년 3월 31일 | $-1.39 | $-1.09 | -27.4% | |
| 2025년 12월 31일 | $-1.41 | $-1.47 | 4.1% | |
| 2025년 9월 30일 | $-1.45 | $-1.25 | -15.8% | |
| 2025년 6월 30일 | $-1.10 | $-1.58 | 30.5% | |
| 2025년 3월 31일 | $-1.68 | $-1.79 | 6.0% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $227M | $251M | $478M | $314M | $77M | $54M | |
| R&D Expense | $244M | $424M | $581M | $1.05B | $1.15B | $160M | $96M | |
| SG&A Expense | $183M | $246M | $385M | $1.43B | $863M | $38M | $29M | |
| Operating Expenses | $485M | $787M | $1.12B | $2.69B | $2.14B | $214M | $126M | |
| Operating Income | $-315M | $-560M | $-864M | $-2.21B | $-1.83B | $-137M | $-72M | |
| Interest Expense | · | · | $93.0K | $106.0K | $2M | $2M | $2M | |
| Other Non-op | $2M | $12M | $-29M | $88M | $-10M | $12M | · | |
| Pretax Income | $-314M | $-548M | $-893M | $-2.12B | $-1.84B | $-125M | $-120M | |
| Income Tax | $-837.0K | $-479.0K | $-71.0K | $-15M | $-1M | $2M | $22.0K | |
| Net Income | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | $-127M | $-119M | |
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 | |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 | |
| Shares (Basic) | 55,457,676 | 51,894,639 | 48,610,507 | 41,976,537 | 1,359,849,000 | 1,274,766,915 | 1,149,000,417 | |
| Shares (Diluted) | 55,457,676 | 51,894,639 | 48,610,507 | 41,995,972 | 1,360,373,000 | 1,274,766,915 | 1,149,000,417 | |
| EBITDA | $-315M | $-560M | $-864M | $-2.21B | · | · | · |
대차대조표
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $562M | $944M | $1.32B | $1.55B | $381M | $495M | |
| Short-term Investments | $255M | $0 | · | · | · | · | · | |
| Receivables | $24M | $22M | $17M | $81M | $132M | $17M | · | |
| Inventory | · | · | $46.0K | $4M | $3M | $3M | · | |
| Prepaid Expense | $25M | $19M | $40M | $52M | $34M | $21M | · | |
| Other Current Assets | · | · | $362.0K | $487.0K | $698.0K | $680.0K | · | |
| Current Assets | $472M | $603M | $1.00B | $1.45B | $1.72B | $427M | · | |
| PP&E (Net) | $167M | $204M | $188M | $315M | $146M | $121M | · | |
| PP&E (Gross) | $355M | $365M | $309M | $408M | $207M | $155M | · | |
| Accum. Depreciation | $188M | $161M | $121M | $93M | $61M | $34M | · | |
| Goodwill | · | $0 | $49M | $60M | $21M | $2M | $2M | |
| Intangibles | $53M | $73M | $83M | $111M | $22M | $3M | · | |
| Other Non-current Assets | $9M | $55M | $58M | $89M | $44M | $6M | · | |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Accounts Payable | $11M | $14M | $9M | $10M | $8M | $14M | · | |
| Accrued Liabilities | · | · | · | $115M | $93M | $31M | · | |
| Short-term Debt | · | · | · | · | · | $300.0K | · | |
| Current Liabilities | $96M | $107M | $164M | $173M | $135M | $73M | · | |
| Capital Leases | $417M | $439M | $222M | $413M | $0 | · | · | |
| Other Non-current Liabilities | $23M | $17M | $24M | $31M | $36M | $3M | · | |
| Total Liabilities | $611M | $661M | $568M | $803M | $504M | $205M | · | |
| Common Stock | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K | $129.0K | · | |
| Paid-in Capital | $6.66B | $6.56B | $6.39B | $6.14B | $3.80B | $929M | · | |
| Retained Earnings | $-6.15B | $-5.84B | $-5.29B | $-4.40B | $-2.30B | $-468M | · | |
| AOCI | $2M | $-2M | $1M | $-3M | $-2M | $0 | · | |
| Stockholders' Equity | $509M | $716M | $1.10B | $1.74B | $1.57B | $470M | · | |
| Liabilities + Equity | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Shares Outstanding | 58,207,298 | 54,365,785,000 | 50,032,873 | 47,299,399 | 40,284,804 | 1,288,596,000 | · |
현금 흐름
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $59M | $63M | $71M | $43M | $29M | $14M | $11M | |
| Stock-based Comp | $82M | $112M | $230M | $1.93B | $1.61B | $476.0K | $771.0K | |
| Deferred Tax | $-1M | $-936.0K | $-801.0K | $-15M | $0 | $0 | · | |
| Amort. of Intangibles | $19M | $18M | $16M | $6M | $1M | $500.0K | $500.0K | |
| Restructuring | $11M | $19M | · | · | · | · | · | |
| Operating Cash Flow | $-171M | $-320M | $-296M | $-252M | $-254M | $-136M | $-45M | |
| CapEx | $8M | $63M | $41M | $52M | $57M | $58M | $22M | |
| Investing Cash Flow | $-240M | $-62M | $-81M | $-67M | $-73M | $-67M | $-75M | |
| Stock Issued | $19M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $408.0K | |
| Net Stock Activity | $19M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $-2M | $-3M | $95M | $1.53B | $90M | $410M | |
| Net Change in Cash | $-393M | $-384M | $-380M | $-223M | $1.21B | $-113M | $291M | |
| Taxes Paid | $192.0K | $0 | $23.0K | $981.0K | $9M | $0 | · | |
| Free Cash Flow | $-179M | $-382M | $-336M | $-304M | · | · | · | |
| Levered FCF | · | · | $-336M | $-305M | · | · | · |
수익성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | · | · | · | |
| Pretax Margin | -184.3% | -241.2% | -355.1% | -444.1% | · | · | · | |
| EBITDA Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| ROA | -25.1% | -36.0% | -42.5% | -91.3% | · | · | · | |
| ROE | -55.8% | -72.3% | -76.0% | -132.4% | · | · | · | |
| ROIC | -61.8% | -78.1% | -78.8% | -126.3% | · | · | · |
유동성 및 지급능력
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.6 | 6.1 | 8.4 | · | · | · | |
| Quick Ratio | 4.7 | 5.4 | 5.9 | 8.1 | · | · | · | |
| Interest Coverage | · | · | -9294.7 | -20839.2 | · | · | · |
효율성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | |
| Receivables Turnover | 7.4 | 11.6 | 5.1 | 4.5 | · | · | · |
주당
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.74 | $13.17 | $0.55 | $0.92 | · | · | · | |
| Revenue / Share | $3.07 | $4.38 | $0.13 | $0.28 | · | · | · | |
| Cash Flow / Share | $-3.08 | $-6.16 | $-0.15 | $-0.15 | · | · | · | |
| Cash / Share | $2.87 | $10.33 | $0.47 | $0.70 | · | · | · | |
| EPS (TTM) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | · | · |
성장률
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -25.1% | -9.7% | -47.4% | 52.2% | 309.4% | · | · | |
| Revenue CAGR 3Y | -29.1% | -10.2% | 48.6% | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $227M | $251M | $478M | $314M | · | · | |
| Net Income TTM | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | · | · | |
| Market Cap | $484M | $534M | $135.29B | $127.90B | · | · | · | |
| P/E | -1.5 | -0.9 | -3.7 | -1.3 | -239.1 | · | · | |
| P/S | 2.8 | 2.4 | 538.0 | 267.7 | · | · | · | |
| P/B | 1.0 | 0.7 | 123.3 | 73.7 | · | · | · | |
| P / Tangible Book | 1.1 | 0.8 | 140.2 | 81.7 | 351.4 | · | · | |
| P / Cash Flow | -2.8 | -1.7 | -457.8 | -507.1 | · | · | · | |
| P / FCF | -2.7 | -1.4 | -402.3 | -420.1 | · | · | · | |
| Earnings Yield | -67.9% | -107.3% | -27.2% | -74.3% | -0.42% | · | · |
손익계산서
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $19M | $33M | $39M | $39M | $38M | $44M | $89M | $56M | $38M | $35M | $55M | $81M | $81M | $98M | $66M | |
| Cost of Revenue | $2M | $3M | · | · | $5M | $4M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $46M | $50M | $50M | $69M | $53M | $71M | $76M | $77M | $134M | $136M | $117M | $157M | $144M | $163M | $178M | $261M | |
| SG&A Expense | $31M | $38M | $46M | $45M | $35M | $40M | $57M | $52M | $66M | $70M | $89M | $82M | $102M | $111M | $121M | $435M | |
| Operating Expenses | $79M | $91M | $104M | $129M | $97M | $119M | $147M | $144M | $279M | $216M | $213M | $342M | $265M | $296M | $329M | $721M | |
| Operating Income | $-59M | $-71M | $-71M | $-90M | $-58M | $-81M | $-104M | $-55M | $-223M | $-178M | $-178M | $-286M | $-184M | $-216M | $-231M | $-655M | |
| Other Non-op | $1M | $-5M | $-11M | $9M | $5M | $-2M | $-4M | $-2M | $6M | $12M | $-34M | $-17M | $11M | $11M | $43M | $-15M | |
| Pretax Income | $-57M | $-76M | $-81M | $-81M | $-53M | $-83M | $-108M | $-57M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-188M | $-670M | |
| Income Tax | $128.0K | $-80.0K | $-643.0K | $1.0K | $-283.0K | $88.0K | $-325.0K | $-375.0K | $190.0K | $31.0K | $-198.0K | $-22.0K | $67.0K | $82.0K | $-15M | $-28.0K | |
| Net Income | $-47M | $-83M | $-81M | $-81M | $-60M | $-91M | $-108M | $-56M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-175M | $-670M | |
| EPS (Basic) | $-0.75 | $-1.39 | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.92 | $-1.08 | $-4.23 | $-3.31 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-48.96 | $-0.41 | |
| EPS (Diluted) | · | · | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.91 | $-1.08 | $-4.23 | $-3.32 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-49.01 | $-0.41 | |
| Shares (Basic) | 62,094,356 | 59,563,454 | · | 55,633,718 | 54,858,982 | 54,241,619 | · | 52,240,559 | 51,370,029 | 50,111,460 | · | 48,770,000 | 1,933,437,000 | 1,914,963,000 | · | 1,630,911,000 | |
| Shares (Diluted) | · | · | · | 55,633,718 | 54,858,982 | 54,241,619 | · | 52,246,129 | 51,375,599 | 50,133,366 | · | 48,770,000 | 1,933,437,000 | 1,916,637,000 | · | 1,630,911,000 | |
| EBITDA | $-59M | $-71M | · | $-90M | $-66M | $-89M | · | $-55M | $-223M | $-178M | · | $-286M | $-184M | $-216M | · | $-653M |
대차대조표
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $144M | $167M | $111M | $204M | $312M | $562M | $616M | $730M | $840M | $944M | $1.05B | $1.11B | $1.21B | $1.32B | $1.30B | |
| Short-term Investments | · | · | $255M | $384M | $356M | $13M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | $13M | $20M | $24M | $21M | $22M | $26M | $22M | $23M | $19M | $24M | · | $62M | $68M | $83M | · | $114M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $70.0K | $391.0K | $3M | · | $6M | |
| Prepaid Expense | $17M | $16M | $25M | $22M | $26M | $20M | $19M | $22M | $34M | $38M | · | $29M | $48M | $34M | · | $38M | |
| Current Assets | $333M | $410M | $472M | $506M | $523M | $565M | $603M | $662M | $783M | $903M | · | $1.14B | $1.22B | $1.33B | · | $1.46B | |
| PP&E (Net) | $157M | $163M | $168M | $177M | $186M | $198M | $204M | $211M | $211M | $196M | · | $202M | $294M | $314M | · | $188M | |
| PP&E (Gross) | $355M | $352M | $358M | $359M | $360M | $361M | $365M | $362M | $347M | $326M | · | $322M | $413M | $421M | · | $271M | |
| Accum. Depreciation | $198M | $189M | $191M | $182M | $173M | $163M | $161M | $151M | $136M | $130M | · | $121M | $118M | $107M | · | $83M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | $48M | $49M | $58M | $59M | $59M | $60M | $29M | |
| Intangibles | $44M | $49M | $57M | $62M | $66M | $69M | $73M | $80M | $91M | $77M | · | $100M | $105M | $109M | · | $48M | |
| Other Non-current Assets | $1M | $40M | $47M | $47M | $47M | $47M | $55M | $60M | $60M | $61M | · | $97M | $98M | $97M | · | $44M | |
| Total Assets | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Accounts Payable | $10M | $16M | $11M | $11M | $11M | $11M | $14M | $16M | $23M | $27M | · | $11M | $14M | $22M | · | $11M | |
| Current Liabilities | $73M | $80M | $96M | $115M | $97M | $116M | $107M | $114M | $166M | $169M | · | $168M | $163M | $192M | · | $125M | |
| Capital Leases | $404M | $411M | $417M | $423M | $429M | $435M | $439M | $446M | $452M | $234M | · | $404M | $411M | $404M | · | · | |
| Other Non-current Liabilities | $16M | $22M | $23M | $17M | $18M | $15M | $17M | $18M | $21M | $25M | · | $19M | $20M | $29M | · | $35M | |
| Total Liabilities | $570M | $590M | $611M | $629M | $618M | $646M | $661M | $683M | $792M | $594M | · | $774M | $788M | $810M | · | $431M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $206.0K | $202.0K | · | $198.0K | $196.0K | $194.0K | · | $165.0K | |
| Paid-in Capital | $6.70B | $6.67B | $6.66B | $6.63B | $6.60B | $6.58B | $6.56B | $6.53B | $6.51B | $6.45B | · | $6.33B | $6.28B | $6.21B | · | $5.67B | |
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B | $-5.67B | $-5.46B | · | $-5.08B | $-4.78B | $-4.60B | · | $-4.23B | |
| AOCI | $950.0K | $1M | $2M | $2M | $2M | $-850.0K | $-2M | $263.0K | $-2M | $-2M | · | $-3M | $-1M | $-2M | · | $-8M | |
| Stockholders' Equity | $420M | $443M | $509M | $560M | $613M | $647M | $716M | $798M | $833M | $987M | $1.10B | $1.25B | $1.50B | $1.61B | $1.74B | $1.43B | |
| Liabilities + Equity | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Shares Outstanding | 63,711,102 | 61,660,788 | 58,207,298 | 56,836,246 | 55,425,334 | 54,698,246 | 54,365,785 | 53,082,000 | 2,078,737,000 | 2,033,624,000 | 50,032,873 | 1,972,725,000 | 1,954,704,000 | 1,933,880,000 | 47,299,399 | 1,648,263,224 |
현금 흐름
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $13M | $14M | $14M | $16M | $15M | $16M | $17M | $17M | $13M | $13M | $21M | $18M | $19M | $16M | $8M | |
| Stock-based Comp | $8M | $16M | $21M | $18M | $22M | $17M | $21M | $14M | $37M | $41M | $43M | $53M | $61M | $73M | $108M | $563M | |
| Amort. of Intangibles | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $1M | |
| Restructuring | · | · | $706.0K | $2M | $4M | · | $-666.0K | $3M | $12M | · | · | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-44M | $-47M | $-48M | $-32M | $-40M | $-52M | $-42M | $-104M | $-84M | $-89M | $-58M | $-74M | $-74M | $-91M | $-105M | $-28M | |
| CapEx | $3M | $2M | $5.0K | $0 | $38.0K | $8M | $14M | $15M | $27M | $7M | $3M | $4M | $14M | $19M | $26M | $13M | |
| Investing Cash Flow | $11M | $23M | $95M | $-73M | $-64M | $-199M | $-13M | $-10M | $-27M | $-12M | $-47M | $-3M | $-11M | $-19M | $30M | $-46M | |
| Stock Issued | · | · | $9M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $-19.0K | $8M | $10M | $-98.0K | $-207.0K | $-203.0K | $-465.0K | $-226.0K | $-845.0K | $-632.0K | $-315.0K | $-1M | $-888.0K | $98M | $-280.0K | |
| Net Change in Cash | $-17M | $-24M | $55M | $-94M | $-104M | $-250M | $-56M | $-114M | $-111M | $-102M | $-105M | $-77M | $-87M | $-111M | $24M | $-75M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Free Cash Flow | · | $-49M | · | · | · | $-59M | · | · | · | $-96M | · | · | · | $-110M | · | · |
수익성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| Net Margin | -231.7% | -424.1% | · | -207.9% | -121.6% | -188.2% | · | -63.3% | -386.4% | -437.2% | · | -546.4% | -215.1% | -254.0% | · | -1007.6% | |
| Pretax Margin | -283.8% | -391.0% | · | -207.9% | -122.1% | -188.1% | · | -63.8% | -386.1% | -437.2% | · | -546.5% | -215.0% | -253.9% | · | -1007.7% | |
| EBITDA Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| ROA | -4.2% | -7.1% | · | -6.0% | -4.2% | -6.3% | · | -3.2% | -11.1% | -8.3% | · | -15.5% | -8.1% | -9.2% | · | -33.3% | |
| ROE | -9.0% | -15.2% | · | -11.9% | -8.3% | -11.1% | · | -5.5% | -18.6% | -12.8% | · | -22.5% | -11.4% | -12.9% | · | -44.8% | |
| ROIC | -14.0% | -16.1% | · | -16.1% | -10.6% | -13.8% | · | -6.9% | -26.8% | -18.0% | · | -22.9% | -12.2% | -13.4% | · | -45.5% |
유동성 및 지급능력
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 5.2 | · | 4.4 | 5.4 | 4.9 | · | 5.8 | 4.7 | 5.3 | · | 6.8 | 7.5 | 6.9 | · | 11.7 | |
| Quick Ratio | 1.3 | 2.1 | · | 4.5 | 6.0 | 3.0 | · | 5.6 | 4.5 | 5.1 | · | 6.6 | 7.2 | 6.7 | · | 11.3 |
효율성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.8 | · | 1.7 | 2.4 | 1.9 | · | 2.1 | 1.3 | 0.7 | · | 0.6 | 0.7 | 0.6 | · | 0.8 |
주당
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.60 | $7.19 | · | $9.85 | $11.06 | $11.84 | · | $15.03 | $0.40 | $0.49 | · | $0.64 | $0.77 | $0.83 | · | $0.87 | |
| Revenue / Share | · | · | · | $0.70 | $0.90 | $0.89 | · | $1.70 | $0.03 | $0.02 | · | $0.03 | $0.04 | $42.11 | · | $0.04 | |
| Cash Flow / Share | · | · | · | · | · | $-0.95 | · | · | · | $-0.04 | · | · | · | $-47.26 | · | · | |
| Cash / Share | $1.33 | $2.33 | · | $1.95 | $3.67 | $5.71 | · | $11.61 | $0.35 | $0.41 | · | $0.53 | $0.57 | $0.62 | · | $0.79 | |
| EPS (TTM) | $-5.64 | $-5.64 | · | $-6.14 | $-5.77 | $-8.90 | · | $-20.59 | $-25.72 | $-21.58 | · | $-55.42 | $-49.62 | $-49.94 | · | $-2.40 |
가치 평가 (TTM)
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $131M | · | $160M | $210M | $227M | · | $218M | $184M | $209M | · | $315M | $326M | $390M | · | $528M | |
| Net Income TTM | $-291M | $-304M | · | $-340M | $-315M | $-472M | · | $-651M | $-898M | $-854M | · | $-857M | $-1.22B | $-1.72B | · | $-3.53B | |
| Market Cap | $631M | $378M | · | $829M | $624M | $312M | · | $433M | $27.77B | $94.36B | · | $142.83B | $145.43B | $102.88B | · | $205.70B | |
| P/E | -1.8 | -1.1 | · | -2.4 | -1.9 | -0.6 | · | -0.4 | -0.5 | -2.2 | · | -1.3 | -1.5 | -1.1 | · | -52.0 | |
| P/S | 5.6 | 2.9 | · | 5.2 | 3.0 | 1.4 | · | 2.0 | 150.7 | 452.1 | · | 453.4 | 446.2 | 263.8 | · | 389.7 | |
| P/B | 1.5 | 0.9 | · | 1.5 | 1.0 | 0.5 | · | 0.5 | 33.3 | 95.6 | · | 114.0 | 96.7 | 64.0 | · | 143.4 | |
| P / Tangible Book | 1.7 | 1.0 | · | 1.7 | 1.1 | 0.5 | · | 0.6 | 37.4 | 109.5 | · | 130.5 | 108.6 | 71.4 | · | 151.5 | |
| P / Cash Flow | · | -8.1 | · | · | · | -6.1 | · | · | · | -1057.2 | · | · | · | -1135.8 | · | · | |
| Earnings Yield | -56.9% | -92.0% | · | -42.1% | -51.3% | -156.1% | · | -252.6% | -192.5% | -46.5% | · | -76.5% | -66.7% | -93.9% | · | -1.9% |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 매출 | $170M | $227M | $251M | $478M | $314M |
| 영업이익률 % | -185.3% | -246.5% | -343.8% | -462.4% | · |
| 순이익 | $-313M | $-547M | $-893M | $-2.10B | $-1.83B |
| 희석 EPS | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 유동비율 | 4.9 | 5.6 | 6.1 | 8.4 | · |
| 당좌 비율 | 4.7 | 5.4 | 5.9 | 8.1 | · |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-179M | $-382M | $-336M | $-304M | · |
기관 투자자 (13F) 201개의 제출자 · $379.7M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
보유자
201
보유 가치
$379.7M
신규 포지션
31
청산 포지션
17
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 31 (-1 이전 분기 대비) | 17 (-12 이전 분기 대비) | 71 (+18 이전 분기 대비) | 37 (-5 이전 분기 대비) | +4.5M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| BlackRock, Inc. | $42,443,568 | 4,282,903 | 11.18% | 주식 |
| VIKING GLOBAL INVESTORS LP | $35,449,338 | 3,577,128 | 9.33% | 주식 |
| Erste Asset Management GmbH | $25,902,147 | 2,536,939 | 6.82% | 주식 |
| VANGUARD GROUP INC | $24,106,911 | 2,900,952 | 6.35% | 주식 |
| BAILLIE GIFFORD & CO | $23,701,242 | 2,391,649 | 6.24% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $20,685,074 | 2,087,293 | 5.45% | 주식 |
| Anchorage Capital Group, L.L.C. | $17,306,457 | 1,746,363 | 4.56% | 주식 |
| Legal & General Group Plc | $16,543,944 | 1,669,419 | 4.36% | 주식 |
| STATE STREET CORP | $14,591,187 | 1,472,370 | 3.84% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $12,112,753 | 1,222,016 | 3.19% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9,293,628 | 937,803 | 2.45% | 주식 |
| Allianz Asset Management GmbH | $7,787,258 | 785,798 | 2.05% | 주식 |
| UBS Group AG | $6,854,341 | 691,659 | 1.80% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $6,329,279 | 638,676 | 1.67% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $6,160,304 | 621,625 | 1.62% | 주식 |
| SB INVESTMENT ADVISERS (UK) LTD | $6,052,324 | 610,729 | 1.59% | 주식 |
| GOLDMAN SACHS GROUP INC | $6,019,096 | 607,376 | 1.59% | 주식 |
| BANK OF AMERICA CORP /DE/ | $5,409,393 | 545,852 | 1.42% | 주식 |
| Prescott Group Capital Management, L.L.C. | $5,369,684 | 541,845 | 1.41% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $5,349,973 | 539,856 | 1.41% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4,109,677 | 414,700 | 1.08% | 콜 옵션 |
| NORTHERN TRUST CORP | $4,014,948 | 405,141 | 1.06% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3,910,555 | 394,607 | 1.03% | 주식 |
| EXCHANGE TRADED CONCEPTS, LLC | $3,555,540 | 358,783 | 0.94% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $3,480,392 | 351,200 | 0.92% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $3,326,886 | 335,710 | 0.88% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $3,097,598 | 312,573 | 0.82% | 주식 |
| Coastal Bridge Advisors, LLC | $2,743,256 | 276,817 | 0.72% | 주식 |
| Invesco Ltd. | $2,098,175 | 211,723 | 0.55% | 주식 |
| BALANCE CAPITAL PARTNERS L.P. | $1,972,179 | 199,009 | 0.52% | 주식 |
| ALGERT GLOBAL LLC | $1,784,395 | 180,060 | 0.47% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $1,746,449 | 176,231 | 0.46% | 주식 |
| Bank of New York Mellon Corp | $1,689,463 | 170,481 | 0.44% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $1,637,935 | 165,281 | 0.43% | 주식 |
| PEAK6 LLC | $1,619,294 | 163,400 | 0.43% | 콜 옵션 |
| CAXTON ASSOCIATES LLP | $1,532,552 | 154,647 | 0.40% | 주식 |
| D. E. Shaw & Co., Inc. | $1,499,938 | 151,356 | 0.39% | 주식 |
| Nuveen, LLC | $1,455,234 | 146,845 | 0.38% | 주식 |
| MORGAN STANLEY | $1,430,152 | 144,314 | 0.38% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1,387,400 | 140,000 | 0.37% | 주식 |
| JPMORGAN CHASE & CO | $1,368,548 | 134,040 | 0.36% | 주식 |
| CITADEL ADVISORS LLC | $1,297,565 | 130,935 | 0.34% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,297,219 | 130,900 | 0.34% | 풋 옵션 |
| a16z Capital Management, L.L.C. | $1,075,909 | 108,568 | 0.28% | 주식 |
| CITADEL ADVISORS LLC | $1,073,253 | 108,300 | 0.28% | 콜 옵션 |
| Numerai GP LLC | $1,036,606 | 104,602 | 0.27% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $974,718 | 98,357 | 0.26% | 주식 |
| WOLVERINE TRADING, LLC | $964,467 | 72,900 | 0.25% | 콜 옵션 |
| Ensign Peak Advisors, Inc | $931,332 | 93,979 | 0.25% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $803,592 | 81,089 | 0.21% | 주식 |
행동주의자 및 5% 이상 소유자 4 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Reshma P. Shetty, Barry Canton | 2025년 2월 14일 | 9.50% | 수정본 | · | SEC |
| Jason Kelly ×4 제출 서류 | 2024년 2월 14일 | · | 최초 제출 | · | SEC |
| Reshma Shetty, Bartholomew Canton ×4 제출 서류 | 2024년 2월 14일 | · | 최초 제출 | · | SEC |
| VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 제출 서류 | 2022년 3월 4일 | · | 최초 제출 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
회사 내부자 17 명의 내부자 · 5 임원 · 13 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Jason R Kelly | Chief Executive Officer & Founder | 2026년 7월 28일 A | 316,483 | 0 | 2 | $-1,374,823 |
| Steven P. Coen | Chief Financial Officer | 2026년 8월 21일 M | 51,851 | 0 | 10 | $-348,032 |
| Mark E. Dmytruk | Chief Financial Officer | 2025년 5월 20일 M | 46,226 | 0 | 0 | $0 |
| Reshma P. Shetty | President & Founder | 2026년 7월 28일 A | 436,422 | 0 | 3 | $-977,101 |
| Marie E. Fallon | Chief Accounting Officer | 2023년 5월 1일 M | 183,010 | 0 | 0 | $0 |
| Christian O Henry | 이사 | 2026년 9월 15일 S | 19,310 | 0 | 1 | $-35,400 |
| Sri Kosuri | 이사 | 2026년 6월 11일 A | 24,067 | 0 | 0 | $0 |
| Ross Fubini | 이사 | 2026년 6월 11일 A | 10,822 | 0 | 0 | $0 |
| Harry Sloan | 이사 | 2026년 6월 11일 A | 271,418 | 0 | 0 | $0 |
| Shyam Sankar | 이사 | 2025년 6월 12일 A | 72,372 | 0 | 0 | $0 |
| Kathy Hopinkah Hannan | 이사 | 2025년 6월 11일 M | 15,003 | 0 | 0 | $0 |
| Myrtle S Potter | 이사 | 2025년 6월 11일 M | 10,822 | 0 | 0 | $0 |
| Arie Belldegrun | 이사 | 2024년 6월 13일 A | 194,925 | 0 | 0 | $0 |
| Reshma Kewalramani | 이사 | 2024년 6월 12일 M | 186,002 | 0 | 0 | $0 |
| Marijn E Dekkers | 이사 | 2024년 6월 12일 M | 386,480 | 0 | 0 | $0 |
| Eagle Equity Partners III, LLC | 이사 | 2021년 9월 16일 D | 31,590,948 | 0 | 0 | $0 |
| Barry Canton | 10% 소유주 | 2026년 7월 28일 A | 436,422 | 0 | 3 | $-977,101 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 25 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 0.69% | 355,179 NS | 2026년 7월 31일 | N-PORT |
| IDNA · iShares Trust | 0.31% | 115,910 SH | 2026년 9월 11일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.08% | 167,123 SH | 2026년 10월 1일 | 일간 |
| IWC · iShares Trust | 0.08% | 160,915 SH | 2026년 9월 11일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 41,498 SH | 2026년 8월 19일 | 일간 |
| IBB · iShares Trust | 0.02% | 379,730 SH | 2026년 9월 11일 | 일간 |
| RSSL · Global X Funds | 0.01% | 22,732 NS | 2026년 7월 31일 | N-PORT |
| IWM · iShares Trust | 0.01% | 1,228,746 SH | 2026년 9월 11일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 549,889 SH | 2026년 8월 19일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 274,008 SH | 2026년 8월 19일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.01% | 112,735 SH | 2026년 8월 19일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.00% | 85,360 NS | 2026년 7월 31일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 2,967 NS | 2026년 7월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.00% | 17,486 NS | 2026년 7월 31일 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 4,528 NS | 2026년 7월 31일 | N-PORT |
| VEGN · ETF Series Solutions | 0.00% | 324 NS | 2026년 7월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4,838 NS | 2026년 7월 31일 | N-PORT |
| IWV · iShares Trust | 0.00% | 22,370 SH | 2026년 9월 3일 | 일간 |
| ITOT · iShares Trust | 0.00% | 66,426 SH | 2026년 9월 11일 | 일간 |
| DFAC · Dimensional ETF Trust | 0.00% | 29,590 NS | 2026년 7월 31일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 5,670 NS | 2026년 7월 31일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 10,065 NS | 2026년 7월 31일 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,489,851 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,264 SH | 2026년 8월 19일 | 일간 |
| IWN · iShares Trust | · | 443,818 SH | 2026년 9월 11일 | 일간 |
DNA 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
평점 · 10 명의 애널리스트
매도
중앙값 목표
$7.00
-43.3%
0 0.0%
적극 매수
0 0.0%
매수
3 30.0%
보유
5 50.0%
매도
2 20.0%
적극 매도
12개월 목표 주가
2 명의 애널리스트 · 2026-10-03평균 목표 $7.00 -43.3%
모든 목표가 상회 →
현재가 $12.35
저가$5.00
평균$7.00
고가$9.00
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | · |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | · |
| BLFS | · | -241.8 | 28.9% | · | · | · |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | · |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | · | · | · | · | · | · |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
최신 뉴스 이 회사 관련 최근 헤드라인
Here's the "Magnificent Seven" Stock Cathie Wood Is Piling Into Now
Nasdaq · 2개월 전
Yahoo announces AI-powered experiences for Yahoo Finance and Yahoo Sports
Yahoo Finance · 3개월, 4주 전
This Warren Buffett Stock Is Beating the S&P 500 in 2026
Nasdaq · 3개월, 4주 전
캘리포니아 법무총장, 2023년 데이터 유출에 따른 23andMe 후계사 제소
BBC Business · 4개월 전
DNA 자가 채취 키트 광고, 오해의 소지가 있어 금지됨
BBC Business · 4개월, 1주 전
짐 크레이머, BillionToOne에 대해: "매수하라고 말합니다"
Yahoo Finance · 4개월, 2주 전
태양화상에서 영감을 받은 새로운 에너지 저장 방법
BBC Business · 4개월, 3주 전
마리화나 판매업체, 소비자에게 위험 경고 누락 혐의로 피소
ZeroHedge · 4개월, 3주 전
1개월 만에 30% 상승, Zcash가 비트코인보다 더 나은 투자처일까?
Yahoo Finance · 5개월, 1주 전
SCHQ vs. TLT: 동일한 국채 DNA, 매우 다른 비용 및 만기
Nasdaq · 5개월, 2주 전
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
출처: SEC 10-Q 제출 8월 6, 2026